header-logo
background-image

LFB Research Grant in Immunology 2024

LFB's immunology research grant scheme aims to support the work of healthcare professionals in the fields of immunodeficiency and immune-mediated neuropathy. 

Proposals are sought for research that aims to improve the management and/or quality of life of patients treated within licensed indications of intravenous immunoglobulins.

The grant 

The fourth LFB Immunology research grant awards are planned for 2024. 

  • ONE PROJECT IN IMMUNODEFICIENCIES FIELD

  • ONE PROJECT IN THE IMMUNE-MEDIATED NEUROPATHIES FIELD 

The amount of each award is €15000

Eligibility Criteria 

Healthcare Providers (HCP), non-Professor, from predefined countries can apply with a project that fulfills the aim of the program.

No products nor placebo are part of the award and could not be requested as a replacement for the award.

Project Scope:

  • Increase the awareness of Immune-mediated disorders in terms of diagnosis or patient management.   

  • Improve the overall quality of life of patients.

  • In patients treated within the licensed indications of Intravenous Immunoglobulins .

Eligible countries

Austria, Belgium, France, Germany, Greece, Italy, Mexico, Spain, Turkey.

image

Review Committee

Projects fulfilling the eligibility criteria will be reviewed by the Grant Jury. A member of LFB's medical staff will sit on the jury as an observer and will not take part in the decision-making process.

image

They have won the previous editions

Discover the previous winners and their awarded projects

Composition of The jury

For immunodeficiency projects

image
Prof. Javier Carbone - Spain
image
Prof. Francisco Espinosa Rosales - Mexico
image
Dr. Nizar Mahlaoui - France
image
Prof. Stephen Jolles - United Kingdom
image
Dr. med. Leif Hanitsch - Germany

For immune-mediated neuropathy projects

image
Prof. Hans-Peter Hartung - Germany
image
Prof. Yeşim Parman - Turkey
image
Prof. Yusuf A. Rajabally - United Kingdom
image
Prof. Jean-Marc Léger - France
image
Prof. Steven Vargas - Mexico

General information

Opening date for applications:  01 January 2024

Application deadline:

  • Immune-mediated neuropathies projects: 15 November 2024

  • Immunodeficiency projects: 07 November 2024

To apply:

  • Download and send all the requested documents (see below) to: immunology.grant@lfb.fr 

  • Feedback will be provided to applicants by mid-December 2024

  • For further information, please contact: immunology.grant@lfb.fr

How to apply 

The submission file (In English) includes:

 

  • Identity of the participant: Please fill out the Curriculum Vitae document (2 pages maximum)

  • Short description of the team

  • A referencing letter from the Head of the service as a supporter of the project

  • Publications list of the candidate/team related to the research

  • The candidate must indicate any conflict of interest, with one of the members of the Review Committee.

Description of the project (5 pages maximum):

  • The rationale of the research and how it answers the chosen unmet need;

  • The objective of the research and expected results;

  • Nature of the work and relevance of the methodology;

  • Timelines and budget, feasibility, and difficulties to foresee: the project must not exceed 18 months (beginning from the acceptance project by the committee);

  • Applicant must declare any foreseen difficulties.

image

Would you like to receive the latest scientific updates ?

Subscribe to our newsletter to receive the upcoming congress highlights.

Application Documents

image
Project proposal template
image
Reference letter template
image
Data protection notice
image
CV template

Award attribution

The prices will be awarded at a scientific congress or meeting, for which sponsorship will also be provided by LFB. Details will be notified to the winners.

 

Pharmacovigilance notice

If the selected project includes any LFB IVIg product, the applicant must follow LFB pharmacovigilance procedures. A pharmacovigilance notice will be provided to the applicant to inform them of the applicable pharmacovigilance procedures.

Legal information

Privacy policy

Heathcare Professional Confidentiality (HCP)

Research Grant rules